ARVO meeting will be held in Salt Lake City, Utah and feature presentation on clinical trials from around the globe.

Many of Laughing Water Capital's most successful investments have worked as well. What are the top 5 investments in Q1 2025?

San Antonio's Texas Biomed CEO responds to potentially major changes in the FDA's approach to drug development research.

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

I absolutely believe to my core we are on the cusp of a huge breakthrough," said Sen. Mark Warner, D-Va, during a visit to ...

Robert F. Kennedy Jr.'s overhaul of federal health agencies will likely impact how Americans get health care, prescription ...

For the first quarter of 2025, a Class A investment in Laughing Water Capital returned approximately -13%. Over the same ...

“A low vision pet will struggle most in an environment that is loud and lacking identifiable touch cues,” Vallone said. “It ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...

and that seems a tremendous shame to me,” laid-off NIOSH Biomedical Engineer Bill Lindsley said. Many of the laid-off workers ...

Ending clinical trials with no warning can put patients at risk.

Researchers at Northwestern University say the device could revolutionize how we monitor the health and recovery of ...